Mon Dec 16 22:30:14 UTC 2024: **Hamps Bio Launches INR 6.22 Crore IPO at ₹51 per Share**

**Surat, Gujarat, India –** Hamps Bio, a Gujarat-based pharmaceutical and FMCG company, has launched its initial public offering (IPO). The company, which manufactures and distributes a wide range of pharmaceutical formulations and freeze-dried/frozen food products under the “Hamps” and “FzyEzy” brands respectively, is offering 6.22 crore shares at a price of ₹51 per share.

Hamps Bio’s product portfolio includes tablets, syrups, capsules, injectables, oils, gels, and powders, alongside a range of frozen and freeze-dried fruits, vegetables, herbs, and flowers. The company distributes its products through over 50 distributors and major e-commerce platforms including Amazon (US, Canada, and EU), Flipkart, and JioMart. Its pharmaceutical products are currently marketed in 8 Indian states and union territories, while its FMCG products reach 6 countries and 22 states and union territories. As of October 31, 2024, Hamps Bio offered over 180 unique products.

The IPO is managed by Marwadi Chandarana Intermediaries Brokers Private Limited and the allotment status will be available on Bigshare Services’ website. The offer lot size is 2,000 shares. While a grey market premium (GMP) of ₹35 per share is currently being reported, investors are urged to conduct thorough due diligence before investing. The company’s promoters include Herrik Shah, Shrenik Shah, Pallavi Shah, and Mitali Shah. Further details can be found on Hamps Bio’s website: http://www.hampsbio.com.

**Disclaimer:** This news article is for informational purposes only and does not constitute investment advice. Consult with a financial advisor before making any investment decisions.

Read More